SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Feb-24 4:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-Feb-24 | Private Sale | 825,000 | $14.90 | $12,292,500.00 | (18%) 4.66M to 3.84M | |
02-Feb-24 4:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 31-Jan-24 | Private Sale | 500,000 | $15.00 | $7,500,000.00 | (10%) 5.16M to 4.66M | |
28-Sep-23 4:27 PM View: | Enliven Therapeutics, Inc. (ELVN) | 26-Sep-23 | Private Sale | 197,500 | $15.00 | $2,962,500.00 | (4%) 5.36M to 5.16M | |
28-Aug-23 4:20 PM View: | Enliven Therapeutics, Inc. (ELVN) | 24-Aug-23 | Private Sale | 440,000 | $16.00 | $7,040,000.00 | (8%) 5.8M to 5.36M | |
28-Feb-23 4:29 PM View: | Cincor Pharma, Inc. (CINC) | 24-Feb-23 | Disposition (change in control) | 4,937,650 | -- | -- | (100%) 4.94M to 0 | |
17-Aug-22 8:01 PM View: | Cincor Pharma, Inc. (CINC) | 15-Aug-22 | Purchase | 600,000 | $30.00 | $18,000,000.00 | 14% 4.34M to 4.94M | |
13-Jan-22 4:45 PM View: | Cincor Pharma, Inc. (CINC) | 11-Jan-22 | Conversion Duplicate | 3,867,650 | -- | -- | 100% 0 to 3.87M | |
13-Jan-22 4:45 PM View: | Cincor Pharma, Inc. (CINC) | 11-Jan-22 | Purchase | 470,000 | $16.00 | $7,520,000.00 | 12% 3.87M to 4.34M |